3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
15
Neoplasms
10
Carcinoma, Renal Cell
8
Carcinoma, Hepatocellular
8
Melanoma
7
Carcinoma, Non-Small-Cell Lung
7
Endometrial Neoplasms
6
Thyroid Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Recurrence
4
Thyroid Cancer, Papillary
3
Stomach Neoplasms
3
Neuroendocrine Tumors
3
Colorectal Neoplasms
3
Adenocarcinoma, Follicular
3
Ovarian Neoplasms
2
Osteosarcoma
2
Neoplasm Metastasis
2
Lymphoma
2
Lung Neoplasms
2
Glioma
2
Carcinoma, Transitional Cell
2
Carcinoma
2
Biliary Tract Neoplasms
2
Uveal Melanoma
1
Triple Negative Breast Neoplasms
1
Thyroid cancer, medullary
1
Thyroid cancer, Hurthle cell
1
Thyroid Diseases
1
Thyroid Carcinoma, Anaplastic
1
Interventions
napabucasin
2
Irinotecan
2
Gemcitabine
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
sipuleucel-T
1
pralsetinib
1
pembrolizumab
1
luprolide acetate gel depot
1
catumaxomab
1
Vaccines
1
Papillomavirus Vaccines
1
Papanicolaou Test
1
Leuprolide
1
Leucovorin
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Human Papillomavirus DNA Tests
1
Fluorouracil
1
Colposcopy
1
Cisplatin
1
Capecitabine
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasms, Glandular and Epithelial
×
lenvatinib
×
Clear all
No trials found.